List of Tables
Table 1. Global Therapeutic Cancer Vaccines Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Therapeutic Cancer Vaccines Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Therapeutic Cancer Vaccines Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Therapeutic Cancer Vaccines Market Competitive Situation by Manufacturers in 2021
Table 5. Global Therapeutic Cancer Vaccines Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Therapeutic Cancer Vaccines Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Therapeutic Cancer Vaccines Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Therapeutic Cancer Vaccines Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Therapeutic Cancer Vaccines Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Therapeutic Cancer Vaccines Manufacturing Sites and Area Served
Table 11. Manufacturers Therapeutic Cancer Vaccines Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Therapeutic Cancer Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Therapeutic Cancer Vaccines as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Therapeutic Cancer Vaccines Sales by Region (2017-2022) & (K Units)
Table 16. Global Therapeutic Cancer Vaccines Sales Market Share by Region (2017-2022)
Table 17. Global Therapeutic Cancer Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Therapeutic Cancer Vaccines Revenue Market Share by Region (2017-2022)
Table 19. North America Therapeutic Cancer Vaccines Sales by Country (2017-2022) & (K Units)
Table 20. North America Therapeutic Cancer Vaccines Sales Market Share by Country (2017-2022)
Table 21. North America Therapeutic Cancer Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Therapeutic Cancer Vaccines Revenue Market Share by Country (2017-2022)
Table 23. Europe Therapeutic Cancer Vaccines Sales by Country (2017-2022) & (K Units)
Table 24. Europe Therapeutic Cancer Vaccines Sales Market Share by Country (2017-2022)
Table 25. Europe Therapeutic Cancer Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Therapeutic Cancer Vaccines Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Therapeutic Cancer Vaccines Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Therapeutic Cancer Vaccines Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Therapeutic Cancer Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Therapeutic Cancer Vaccines Revenue Market Share by Region (2017-2022)
Table 31. Latin America Therapeutic Cancer Vaccines Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Therapeutic Cancer Vaccines Sales Market Share by Country (2017-2022)
Table 33. Latin America Therapeutic Cancer Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Therapeutic Cancer Vaccines Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Therapeutic Cancer Vaccines Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Therapeutic Cancer Vaccines Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Therapeutic Cancer Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Therapeutic Cancer Vaccines Revenue Market Share by Country (2017-2022)
Table 39. Global Therapeutic Cancer Vaccines Sales by Type (2017-2022) & (K Units)
Table 40. Global Therapeutic Cancer Vaccines Sales Market Share by Type (2017-2022)
Table 41. Global Therapeutic Cancer Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Therapeutic Cancer Vaccines Revenue Share by Type (2017-2022)
Table 43. Global Therapeutic Cancer Vaccines Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Therapeutic Cancer Vaccines Sales (K Units) by Application (2017-2022)
Table 45. Global Therapeutic Cancer Vaccines Sales Market Share by Application (2017-2022)
Table 46. Global Therapeutic Cancer Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Therapeutic Cancer Vaccines Revenue Share by Application (2017-2022)
Table 48. Global Therapeutic Cancer Vaccines Price by Application (2017-2022) & (US$/Unit)
Table 49. Antigenics Corporation Information
Table 50. Antigenics Description and Business Overview
Table 51. Antigenics Therapeutic Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Antigenics Therapeutic Cancer Vaccines Product
Table 53. Antigenics Recent Developments/Updates
Table 54. Asterias Biotherapeutics Corporation Information
Table 55. Asterias Biotherapeutics Description and Business Overview
Table 56. Asterias Biotherapeutics Therapeutic Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Asterias Biotherapeutics Therapeutic Cancer Vaccines Product
Table 58. Asterias Biotherapeutics Recent Developments/Updates
Table 59. Avax Technologies Corporation Information
Table 60. Avax Technologies Description and Business Overview
Table 61. Avax Technologies Therapeutic Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Avax Technologies Therapeutic Cancer Vaccines Product
Table 63. Avax Technologies Recent Developments/Updates
Table 64. Bayer Corporation Information
Table 65. Bayer Description and Business Overview
Table 66. Bayer Therapeutic Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Bayer Therapeutic Cancer Vaccines Product
Table 68. Bayer Recent Developments/Updates
Table 69. GlaxoSmithKline Corporation Information
Table 70. GlaxoSmithKline Description and Business Overview
Table 71. GlaxoSmithKline Therapeutic Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. GlaxoSmithKline Therapeutic Cancer Vaccines Product
Table 73. GlaxoSmithKline Recent Developments/Updates
Table 74. Mayo Clinic Corporation Information
Table 75. Mayo Clinic Description and Business Overview
Table 76. Mayo Clinic Therapeutic Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Mayo Clinic Therapeutic Cancer Vaccines Product
Table 78. Mayo Clinic Recent Developments/Updates
Table 79. Merck Corporation Information
Table 80. Merck Description and Business Overview
Table 81. Merck Therapeutic Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Merck Therapeutic Cancer Vaccines Product
Table 83. Merck Recent Developments/Updates
Table 84. Moderna Corporation Information
Table 85. Moderna Description and Business Overview
Table 86. Moderna Therapeutic Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Moderna Therapeutic Cancer Vaccines Product
Table 88. Moderna Recent Developments/Updates
Table 89. Northwest Biotherapeutics Corporation Information
Table 90. Northwest Biotherapeutics Description and Business Overview
Table 91. Northwest Biotherapeutics Therapeutic Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. Northwest Biotherapeutics Therapeutic Cancer Vaccines Product
Table 93. Northwest Biotherapeutics Recent Developments/Updates
Table 94. VAXIMM Corporation Information
Table 95. VAXIMM Description and Business Overview
Table 96. VAXIMM Therapeutic Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. VAXIMM Therapeutic Cancer Vaccines Product
Table 98. VAXIMM Recent Developments/Updates
Table 99. Production Base and Market Concentration Rate of Raw Material
Table 100. Key Suppliers of Raw Materials
Table 101. Therapeutic Cancer Vaccines Distributors List
Table 102. Therapeutic Cancer Vaccines Customers List
Table 103. Therapeutic Cancer Vaccines Market Trends
Table 104. Therapeutic Cancer Vaccines Market Drivers
Table 105. Therapeutic Cancer Vaccines Market Challenges
Table 106. Therapeutic Cancer Vaccines Market Restraints
Table 107. Global Therapeutic Cancer Vaccines Sales Forecast by Type (2023-2028) & (K Units)
Table 108. Global Therapeutic Cancer Vaccines Sales Market Share Forecast by Type (2023-2028)
Table 109. Global Therapeutic Cancer Vaccines Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 110. Global Therapeutic Cancer Vaccines Revenue Market Share Forecast by Type (2023-2028)
Table 111. Global Therapeutic Cancer Vaccines Sales Forecast by Application (2023-2028) & (K Units)
Table 112. Global Therapeutic Cancer Vaccines Sales Market Share Forecast by Application (2023-2028)
Table 113. Global Therapeutic Cancer Vaccines Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 114. Global Therapeutic Cancer Vaccines Revenue Market Share Forecast by Application (2023-2028)
Table 115. Global Therapeutic Cancer Vaccines Sales Forecast by Region (2023-2028) & (K Units)
Table 116. Global Therapeutic Cancer Vaccines Sales Market Share Forecast by Region (2023-2028)
Table 117. Global Therapeutic Cancer Vaccines Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 118. Global Therapeutic Cancer Vaccines Revenue Market Share Forecast by Region (2023-2028)
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Therapeutic Cancer Vaccines
Figure 2. Global Therapeutic Cancer Vaccines Market Share by Type in 2021 & 2028
Figure 3. Whole Cell Vaccine Product Picture
Figure 4. Antigen Vaccine Product Picture
Figure 5. Non-specific and Cytokine Strategies Product Picture
Figure 6. Others Product Picture
Figure 7. Global Therapeutic Cancer Vaccines Market Share by Application in 2021 & 2028
Figure 8. Bladder Cancer
Figure 9. Brain Tumors
Figure 10. Breast Cancer
Figure 11. Lung Cancer
Figure 12. Prostate Cancer
Figure 13. Cervical Cancer
Figure 14. Others
Figure 15. Global Therapeutic Cancer Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Therapeutic Cancer Vaccines Market Size (2017-2028) & (US$ Million)
Figure 17. Global Therapeutic Cancer Vaccines Sales (2017-2028) & (K Units)
Figure 18. Therapeutic Cancer Vaccines Sales Share by Manufacturers in 2021
Figure 19. Global Therapeutic Cancer Vaccines Revenue Share by Manufacturers in 2021
Figure 20. The Global 5 and 10 Largest Therapeutic Cancer Vaccines Players: Market Share by Revenue in 2021
Figure 21. Therapeutic Cancer Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 22. Global Therapeutic Cancer Vaccines Sales Market Share by Region (2017-2022)
Figure 23. Global Therapeutic Cancer Vaccines Sales Market Share by Region in 2021
Figure 24. Global Therapeutic Cancer Vaccines Revenue Market Share by Region (2017-2022)
Figure 25. Global Therapeutic Cancer Vaccines Revenue Market Share by Region in 2021
Figure 26. U.S. Therapeutic Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Canada Therapeutic Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Germany Therapeutic Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. France Therapeutic Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. U.K. Therapeutic Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Italy Therapeutic Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Russia Therapeutic Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. China Therapeutic Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Japan Therapeutic Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. South Korea Therapeutic Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. India Therapeutic Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Australia Therapeutic Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Taiwan Therapeutic Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Indonesia Therapeutic Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Thailand Therapeutic Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Malaysia Therapeutic Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Philippines Therapeutic Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Vietnam Therapeutic Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Mexico Therapeutic Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Brazil Therapeutic Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. Argentina Therapeutic Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 47. Turkey Therapeutic Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 48. Saudi Arabia Therapeutic Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 49. UAE Therapeutic Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 50. Sales Market Share of Therapeutic Cancer Vaccines by Type (2017-2022)
Figure 51. Manufacturing Cost Structure of Therapeutic Cancer Vaccines
Figure 52. Manufacturing Process Analysis of Therapeutic Cancer Vaccines
Figure 53. Therapeutic Cancer Vaccines Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
